Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
J Strength Cond Res ; 22(4): 1156-63, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18545194

ABSTRACT

To assess unloaded knee extensor temporal strength changes, healthy subjects without asthma performed 40 continuous days of unilateral limb suspension, whereby their left leg refrained from normal weight-bearing and ambulatory activity. During the 40-day period, subjects performed resistance exercise (REX) with their unloaded leg on an inertial resistance ergometer and, as part of a double-blind design, consumed the maximal oral therapeutic dosage of albuterol (i.e., 16 mg.d) or a placebo (i.e., lactose) with no crossover. Workout data were partitioned into 4 10-day periods that ran consecutively. Dependent strength variables included concentric total work, eccentric total work, concentric average power (CAP), and eccentric average power (EAP). Dependent variables were analyzed with 5 (time) x 2 (group) x 2 (gender) mixed factorial analyses of variance and the Tukey honestly significant difference test. Concentric total work, CAP, and EAP each demonstrated a time-group-gender (p < 0.05) interaction. Female REX-placebo subjects had the greatest percentage of unloaded knee extensor strength loss. However, female REX-albuterol subjects fared best throughout the 40-day period and incurred significant unloaded knee extensor strength gains. Differences in strength changes between male and female REX-albuterol subjects was likely due to the higher relative dosage administered to the latter, as body mass showed a gender (i.e., men > women) effect. Future research may elucidate the ideal dose-response relationship for REX-albuterol treatment for use aboard manned space flights and in other disuse models. Coaches and practitioners should carefully examine their sport-governing bodies' rules on albuterol administration and give the drug only if an athlete's health warrants such treatment.


Subject(s)
Adrenergic beta-Agonists/pharmacology , Ergometry , Muscle Strength/drug effects , Albuterol/pharmacology , Asthma/drug therapy , Double-Blind Method , Female , Humans , Male , Muscle, Skeletal/physiology , Sex Factors , Weight-Bearing/physiology
2.
Aviat Space Environ Med ; 79(6): 577-84, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18581941

ABSTRACT

INTRODUCTION: In-flight ankle extensor (AEXT) strength losses are an impediment to long-term space travel. The current study examines if albuterol helps resistance exercise (RE) abate AEXT strength loss incurred over a 40-d unloading period. METHODS: All subjects (21 men, M; 15 women, W) performed unilateral limb suspension (ULLS) and exercised on a flywheel ergometer (FERG) with their otherwise unloaded AEXT. With a double-blind randomization assignment, subjects either received placebo (PLA, lactose) or albuterol (ALB, 16 mg x d(-1)) via four daily capsule doses with no crossover. FERG calf press workouts done 3 d x wk(-1) provided concentric and eccentric total work (CTW, ETW) and average power (CAP, EAP) measures. Workout data from the 40-d period were averaged and partitioned into four consecutive 10-d periods. Data were compared with a 2 (gender) x 2 (treatment) x 4 (time) MANCOVA, with day 0 AEXT strength measurements and a drug/body mass ratio as covariates. RESULTS: CTW and ETW days 11-20, 21-30, and 31-40, as well as CAP and EAP days 11-20 and 21-30 showed the following significant results: ALB-W > ALB-M, PLA-M > PLA-W. CAP and EAP days 31-40 showed the following significant results: ALB-W, ALB-M, PLA-M > PLA-W. DISCUSSION: The combined RE-albuterol treatment most likely evoked unloaded AEXT strength gains in women due to heightened myofibril sensitivity for Ca+2. Despite a drug/body mass covariate, gender-related differences should be interpreted with caution. Future work should compare absolute and relative beta2 agonist dosages on gender-related muscle mass and strength changes.


Subject(s)
Adrenergic beta-Agonists/therapeutic use , Albuterol/therapeutic use , Exercise , Muscle Strength/drug effects , Muscle Weakness/prevention & control , Weightlessness Countermeasures , Ankle/physiology , Female , Humans , Male , Muscle, Skeletal/drug effects , Sex Factors
3.
J Strength Cond Res ; 19(3): 592-8, 2005 Aug.
Article in English | MEDLINE | ID: mdl-16095408

ABSTRACT

The subjects of this study (n = 20; 16 women, 4 men) performed 10 weeks of leg press training using one of two exercise modes (isoload or isotonic) with no crossover. Their workouts, which were performed 3 times per week, involved 4 sets of 8 repetitions with maximal voluntary effort. Testing was performed pre- and posttraining to examine bone and muscle changes. Posttraining, both groups incurred significant concentric knee extensor strength and leg muscle mass gains, while the percentage of body fat and total body fat mass each decreased. Leg and total body bone mineral densities showed group-by-time interactions, as isoload exercise caused posttraining gains, while isoinertial values were unchanged. Bone resorption assays showed insignificant changes. Isoload training likely involved greater strain magnitudes and rates to evoke higher peak forces and osteogenesis. Transduction of the training stimulus may have involved (a) formation in response to microdamage, and (b) piezoelectric-induced potentials that stimulated site-specific osteoblast activity and osteogenesis.


Subject(s)
Leg/physiology , Musculoskeletal Physiological Phenomena , Physical Education and Training/methods , Absorptiometry, Photon , Adult , Analysis of Variance , Biomechanical Phenomena , Bone Density , Diet , Female , Humans , Male , Stress, Mechanical
4.
J Strength Cond Res ; 19(1): 102-7, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15705021

ABSTRACT

Subjects performed isoload variable resistance exercise (REX) 3 days per week. After 10 weeks, they received a double-blind albuterol (n = 11) or placebo (n = 11) capsule assignment with no crossover and continued training. During the first week of capsule administration, dosages were increased from 4 mg to 16 mg daily and then maintained for 14 days. At weeks 0, 10, and 13, we measured upper arm and thigh cross-sectional area, knee and elbow extensor and flexor (KE, KF, EE, EF) strength at 3 angular velocities, and lean body mass. Data after 10 weeks showed insignificant between-group differences. From weeks 10-13, as subjects continued REX training, albuterol evoked higher (p < 0.05) KE-KF strength gains at multiple velocities versus placebo dosing. A higher lean body mass trend also occurred with albuterol from weeks 10-13. Results suggest that albuterol augments REX to provide greater strength gains from hypertrophic factors than an REX-placebo assignment.


Subject(s)
Adrenergic beta-Agonists/pharmacology , Albuterol/pharmacology , Muscle, Skeletal/drug effects , Physical Education and Training , Weight Lifting/physiology , Administration, Oral , Adolescent , Adult , Body Composition/drug effects , Dose-Response Relationship, Drug , Double-Blind Method , Drug Administration Schedule , Humans , Male
5.
J Strength Cond Res ; 18(4): 753-9, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15574079

ABSTRACT

Hind-limb-suspended rats incur attenuated bone loss with beta(2)-agonists, and humans note similar changes with concurrent resistance exercise. To examine if the beta(2)-agonist albuterol helps resistance exercise reduce unloading-induced bone loss, human subjects performed 40 days of unilateral limb suspension with their left legs, otherwise refraining from normal ambulatory activity. While performing left leg strength training 3 days.week(-1), subjects received a concurrent placebo or albuterol (16 mg.day(-1)) treatment. Left leg muscle and bone changes were analyzed with 2 x 2 analyses of covariance (ANCOVAs). Mechanical loading values were calculated from workouts and compared using a 2 x 5 analysis of variance (ANOVA) and a Tukey post hoc test. The resistance exercise-albuterol assignment evoked significant (p < 0.05) left leg bone mineral content (BMC) gains (+2.24%) after 40 days. During the final unloading days, the resistance exercise-placebo group's mechanical loading data declined (-13.91%) significantly (p < 0.05) versus initial values. A resistance exercise-albuterol assignment likely increased BMC by maintaining the mechanical loading stimulus.


Subject(s)
Adrenergic beta-Agonists/pharmacology , Albuterol/pharmacology , Bone Density/drug effects , Bone Density/physiology , Exercise/physiology , Leg/physiology , Osteoporosis/prevention & control , Adult , Analysis of Variance , Biomechanical Phenomena , Female , Humans , Immobilization , Male , Muscle, Skeletal/physiology
6.
Aviat Space Environ Med ; 75(6): 505-11, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15198276

ABSTRACT

INTRODUCTION: While resistance exercise (REX) attenuates knee extensor (KE) mass and strength deficits during short-term unloading, additional treatments concurrently administered with REX are required to reduce the greater losses seen with longer periods of unloading. METHODS: To determine whether albuterol helps REX attenuate unloading-induced KE losses, two groups of subjects strength trained their left thigh three times per week, and otherwise refrained from ambulatory and weight-bearing activity for 40 d while receiving a capsule dosing treatment (albuterol, placebo) with no crossover. A third group served as unloaded controls (CTRL). On days 0, 20, and 40, the following data were collected from the nonweight-bearing (left) thigh: cross-sectional area (CSA); integrated electromyography (IEMG); and concentric and eccentric KE strength measures. Thigh CSA was estimated using anthropometric methodology. IEMG was used to provide root mean square (RMS) values from submaximal (100 nm) and maximal isometric contractions. Concentric and eccentric strength were measured from eight-repetition unilateral leg press sets. RESULTS: Repeated-measures mixed-factorial 3 x 3 ANCOVAs with day 0 values as a covariate showed group by time interactions for concentric and eccentric total work (CTW, ETW). Tukey's post hoc test showed REX-albuterol evoked significant (p < 0.05) day 40 CTW and ETW gains vs. within-group day 0 and within-time REX-placebo and CTRL values. By days 20 and 40, CTRL subjects incurred significant decrements. CONCLUSIONS: Albuterol augmented the effects of REX to increase CTW and ETW. Research identifying possible mechanisms responsible for such changes, as well as the safety of REX-albuterol administration in other models, is warranted.


Subject(s)
Adrenergic beta-Agonists/pharmacology , Albuterol/pharmacology , Exercise/physiology , Muscle, Skeletal/drug effects , Double-Blind Method , Electromyography , Female , Humans , Isometric Contraction , Knee Joint/physiology , Male
7.
J Strength Cond Res ; 17(3): 608-13, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12930194

ABSTRACT

The impact of two predictor variables (estimated knee extensor fast-twitch fiber percentage, body mass) on performance measures (vertical jump power output, leg press peak angular velocity) were examined. Subjects (25 men, 27 women) performed 5 workouts involving 2 vertical jump, leg press, and 50-repetition isokinetic tests (to estimate knee extensor fast-twitch fiber percentage). Multivariate regression determined the following significant (p < 0.05) vertical jump equations: predicted male power output = -59.3464 + 1.566 (estimated knee extensor fast-twitch muscle fiber percent) + 15.7884 (body mass), predicted female power output = 36.1574 + 3.4248 (estimated knee extensor fast-twitch muscle fiber percent) + 9.8633 (body mass). Leg press peak angular velocity equations were insignificant by gender; thus, pooled data yielded the following: predicted leg press peak angular velocity = 18.6187 + 0.235 (estimated knee extensor fast-twitch muscle fiber percent) + 0.3801 (body mass). Body mass explained more variance for each performance measure.


Subject(s)
Knee Joint/physiology , Muscles/physiology , Adult , Body Mass Index , Female , Humans , Male , Muscle Fibers, Fast-Twitch/physiology , Predictive Value of Tests , Regression Analysis , Torque
SELECTION OF CITATIONS
SEARCH DETAIL
...